Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis
10.1016/j.jpha.2024.100975
- Author:
Cheng WEILUN
1
;
Mi WANQI
;
Wang SHIYUAN
;
Wang XINRAN
;
Jiang HUI
;
Chen JING
;
Yang KAIYUE
;
Jiang WENQI
;
Ye JUN
;
Guo BAOLIANG
;
Zhang YUNPENG
Author Information
1. Department of General Surgery,The Second Affiliated Hospital of Harbin Medical University,Harbin,150001,China
- Keywords:
Triple-negative breast cancer;
Single-cell RNA sequencing;
Epithelial-mesenchymal transition;
Macrophage polarization;
Therapeutic drugs;
Bioinformatics
- From:
Journal of Pharmaceutical Analysis
2024;14(8):1140-1157
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer remains a leading cause of mortality in women worldwide.Triple-negative breast cancer(TNBC)is a particularly aggressive subtype characterized by rapid progression,poor prognosis,and lack of clear therapeutic targets.In the clinic,delineation of tumor heterogeneity and development of effective drugs continue to pose considerable challenges.Within the scope of our study,high hetero-geneity inherent to breast cancer was uncovered based on the landscape constructed from both tumor and healthy breast tissue samples.Notably,TNBC exhibited significant specificity regarding cell prolif-eration,differentiation,and disease progression.Significant associations between tumor grade,prog-nosis,and TNBC oncogenes were established via pseudotime trajectory analysis.Consequently,we further performed comprehensive characterization of the TNBC microenvironment.A crucial epithelial subcluster,E8,was identified as highly malignant and strongly associated with tumor cell proliferation in TNBC.Additionally,epithelial-mesenchymal transition(EMT)-associated fibroblast and M2 macrophage subclusters exerted an influence on E8 through cellular interactions,contributing to tumor growth.Characteristic genes in these three cluster cells could therefore serve as potential therapeutic targets for TNBC.The collective findings provided valuable insights that assisted in the screening of a series of therapeutic drugs,such as pelitinib.We further confirmed the anti-cancer effect of pelitinib in an orthotopic 4T1 tumor-bearing mouse model.Overall,our study sheds light on the unique characteristics of TNBC at single-cell resolution and the crucial cell types associated with tumor cell proliferation that may serve as potent tools in the development of effective anti-cancer drugs.
